SlideShare a Scribd company logo
1 of 9
Download to read offline
THE HEALTH OF
INDIAN PHARMA
MEDICINMANField Force Excellence
TM
January 2015 | www.medicinman.net
Since 2011
Jan-Dec 2014
BRANDST RM 2015BRAINSTORMING FOR PHARMA BRAND MANAGERS
13th
March 2015, Mumbai







FFE 2015FIELD FORCE EXCELLENCE
14th
March 2015, Mumbai
PHARMA'S TWO MOST
AWAITED EVENTS OF
2015 ARE HERE!
Block the Dates: Fri, 13th & Sat, 14th March 2015
The Westin Hotel, Oberoi Garden City, Goregaon East,
Mumbai
Register Now!
BRANDST RM 2015BRAINSTORMING FOR PHARMA BRAND MANAGERS
MEDICINMAN
Kiran Khalap
Salil Kallianpur Amlesh Ranjan
Manish Bhagat
Susan Joshi
13th
March 2015, Mumbai
Anup Soans
Key Topics at BrandStorm 2015
LL How to launch and sustain
brands in a VUCA world
LL Harnessing digital & social
media
LL Patient-centric care
LL Medical Affairs and KOL
management
Target Audience:
Product Managers,
Group Product Managers,
Marketing Managers &
Digital Marketing teams
First announcement; detailed program schedule to
follow
MEDICINMAN







FFE 2015FIELD FORCE EXCELLENCE
14th
March 2015, Mumbai
CEO Breakfast
Shakti Chakraborty
Bhasker Iyer Sujay Shetty
Ganesh Nayak
Key Topics at FFE 2015
The only pharma event in India with a CEO Roundtable
on Field Force Excellence
LL Managing the Millennial
Field Force: Challenges &
Opportunities
LL Social Learning for Field
Force -
A viable option?
LL Data Analytics: Can it
provide actionable
insights for segmented
marketing?
Target Audience:
Sales & Marketing Heads,
SBU Heads, Senior Managers
in HR, Training, SFE and other
Field Force-related functions
First announcement; detailed program
schedule to follow
REGISTRATION
Hosted by www.MedicinMan.net. Organized by Knowledge Media Venturz.
DELEGATE FEE* MATRIX FOR FFE 2015 & BRANDSTORM 2015
All figures in INR FFE BRANDSTORM BOTH
PHARMA DELEGATES 8,500/- 6,500/- 12,000/-
SERVICE PROVIDERS# 15,000/- 15,000/- 25,000/-
EARLY BIRD OFFER (BEFORE 20th
January 2015)
PHARMA DELEGATES 7,500/- 5,500/- 10,000/-
SERVICE PROVIDERS# 12,500/- 12,500/- 20,000/-
To register, make payment and submit payment and delegate details by email to Chhaya Sankath
(chhaya@kmv.co.in) or register online: medicinman.net/2014/12/brandstorm-ffe-2015-registration
CHEQUE PAYMENT
Payment must be made in INR by Cheque / Bank Draft and must be received prior to the conference. Cheques to be issued in
the name of “KNOWLEDGE MEDIA VENTURZ LLP”, payable at Mumbai.
SEND CHEQUES TO:
Chhaya Sankath, A-302, Kshitij C. H. S. L., Off Film City Road, Behind Satellite Towers, Goregaon East,
Mumbai 400 063
PAY BY ACCOUNT TRANSFER
NEFT DETAILS
BANK: AXIS BANK
BRANCH: GOREGAON WEST, MUMBAI (MH), GR FLR, PATKAR COLLEGE,
S V ROAD, GOREGAON WEST, MUMBAI -62.
ACCOUNT NAME: KNOWLEDGE MEDIA VENTURZ LLP
ACCOUNT NO: 913020033732313
IFSC CODE: UTIB0000647
DELEGATE DETAILS (TO BE SENT ALONG WITH DETAILS OF PAYMENT)
NAME:
COMPANY:
DESIGNATION:
ADDRESS: EMAIL: MOBILE:
DETAILS OF CHEQUE/ NEFT TRANSFER:
PAYMENT OPTIONS
*Add Service Tax @ 12.36% #
Only 10 Service Provider passes available, on a first-come, first-serve basis
Market Data: Jan-Dec 2014
Key Insights for December 2014:
1.	 For Month of Dec -14, we have seen the GDs as 5.1% in Volumes, 5.3% in Price Increases
& 3.2% in NIs against a 4.1% in volumes in Dec -13
2.	 Price Increases was at 5.3%, which has been the highest in the last 12 months in the IPM
3.	 There has been a growth registered (10.3%) in this quarter which is higher than the
corresponding Quarter last year (4.3%)
Key Highlights for December 2014:
Key Numbers:
1.	 The IPM clocked 7375 Crs in December 2014
2.	 The Indian Pharma Market grows at 13.6% for the month of December 2014
Corporate:
1.	 For the month of December 2014, amongst the top 10, Ranbaxy grew by 28.7% followed
by Pfizer at 23.1% & Sun Pharma at 21.5%
2.	 21 corporate have crossed the growth of IPM for the month of December 2014 amongst
top 50
3.	 Amongst the top 50 Corporate, Akumentis has the highest growth of 69.4% followed by
Merck at 37.8% & Albert David at 32.0%
4.	 30 Corporate showed growths more than 10% amongst the top 50
5.	 Amongst the 11-20 ranked Corporate Torrent has the highest growth of 31.1% followed by
Macleods at 30.1% & USV at 24.9%
After the peak in Sep 2014, the market showed a dip due to festive season, however for last
2 months the market has be in a positive trend with Dec month at 13.6%
Source: AIOCD Pharmasofttech AWACS
The Health of Indian Pharma: Jan-Dec 2014MEDICINMAN
6.	 Amongst the 51-60 ranked Corporate, Panacea grows at 42.0% followed by Pharmed at
17.7% & Systopic at 17.2%
7.	 Amongst the 61-75 ranked Corporate, Boehringer grew by 62.1% followed by Tablets
India at 23.3% & Serdia at 18.8%
8.	 Ranbaxy enters the 3000 Cr Club, Panacea enters the 300 Cr Club as on MAT Dec 2014
Indian V/S MNCs:
1.	 Indian companies have grown at 12.1% versus 17.5% for MNCs in December 2014
2.	 Amongst the top 50 in MNCs Merck grew by 37.8% followed by Ranbaxy at 28.7%, MSD
at 26.1% & Pfizer at 24.3%
3.	 Under the Non-NLEM category Indian Companies grew at 13.6% whereas MNCs grew at
18.0%
4.	 For the Dec Quarter the MNCs have shown a volume growth of 6.4% versus 1.0% for the
Indian companies
5.	 DPCO V/s Non DPCO Market:
6.	 The DPCO containing molecules market grew at 8.0 % whereas the non DPCO market
grew by 14.8% resulting in an overall growth of 13.6% for December 2014
7.	 NLEM & Non - NLEM Category showed unit growth at 0.7% and 3.2% respectively
8.	 The DPCO 2013 portfolio for Pfizer grew at 13.9%, GSK 1.7%, Ranbaxy 41.9%
December 2014
Val in Cr Units in 000s
Value Growth Unit Growth
IPM 7,357 13.6% 1,579,638 2.7%
NLEM 1,252 8.0% 320,126 0.7%
Non-NLEM 6,123 14.8% 1,259,512 3.2%
Source: AIOCD Pharmasofttech AWACS
The Health of Indian Pharma: Jan-Dec 2014MEDICINMAN
Therapy:
1.	 From therapy perspective 4 therapies have outgrown the IPM growth & 14 therapies have
double digit growths
2.	 Respiratory Market grew at 10.0%, Gastrointestinal market grew at 13.5% , Pain &
Analgesics market grew at 11.3% whereas Anti-infectives grew at 5.2%
3.	 Anti-diabetic market grows at 33.1% & Cardiac at 18.2% in chronic business
4.	 Derma market grew by 19.6% & Urology Market at 29.7%
Regional Dynamics:
1.	 From regional perspective 11 regions have outgrown the IPM growth
2.	 Mumbai market grew the highest at 21.9% followed by Gujarat market at 21.7% & Kerala
Market at 20.7%
3.	 No regions had negative growth in December 2014
Molecules:
1.	 Amoxycillin + Clavulanic Acid Market grew at 8.2% whereas Glimepiride + Metformin
grows at 20.0% at No 2.
2.	 The markets of Paracetamol grew at 5.6%, Atorvastatin 24.0%, Probiotic Microbes at
26.9%, Cefixime 1.1%, Pantoprazole 15.3%, Montelukast + Levocetrizine at 20.4%,
Glimepiride + Metformin + Pioglitazone at 28.1%, Vitamin-D at 29.4%, Hydroquinone
+ Mometasone + Tretinoin at 34.7%, Voglibose + Metformin + Glimepiride at 57.0%,
Leveteracetam at 37.2%, Protein Supplements at 24.1%
Brands:
1.	 Mixtard continues to lead the pack with 41.7 Crs for the Month of Dec -14 with a growth
of 47.8%
2.	 Mixtard grew at 47.8%, Lantus grew at 36.7% & Glycomet- GP grows at 36.3%, Augmentin
grows at 16.2%, amongst the top 10 Brands
3.	 Amongst the Brands who have gained ranks include Clexane (+64), Janumet (+54),
Januvia (+43), Shelcal (+38), Panderm Plus (+31), Istamet (+29), Rosuvas & Jalra (+26),
Novomix, Susten & Jalra-M (+17), Taxim, Pan & Levipil (+15), Zincovit (+13), Dexorange,
Orofer-XT & Tonact (+9), Liv -52(+6), amongst Top 100 Brands over December 13
New Launches in IPM:
1.	 Total 361 SKUs & 185 Brands launched in December 2014
2.	 Top New Brands for December are Biovac V, Ryzodeg & Canmab
3.	 2 New Subgroups got launched as Roflumilast & Cyclobenzaparine + Diclofenac
Source: AIOCD Pharmasofttech AWACS
The Health of Indian Pharma: Jan-Dec 2014MEDICINMAN
CAREERPROGRESSIONRESOURCES
NOWAVAILABLEON
(click on the books to purchase on
flipkart)
SuperVision for the SuperWiser Front-line Manager is a tool to help pharma
professionals transition from super salesmen to great front-line managers and
leaders. The book will equip front-line managers to Manage, Coach, Motivate
and Lead their teams to deliver outstanding performance. An engaging read,
filled with examples and illustrations, SuperVision for the SuperWiser Front-line
Manager has been used by thousands of managers across the industry.
HardKnocks for the GreenHorn is a specially crafted training manual to enable
Medical Representatives to gain the Knowledge, Skills and Attitude needed to
succeed in the competitive arena of pharma field sales. Medical Representatives
joining the field are often not aware about the key success factors of their job and as a result they get
discouraged when things don’t go as planned. HardKnocks for the GreenHorn is a powerful learning and
motivational tool for field sales managers to build their sales teams.
RS 799 699/-
(Limited period offer.Till stocks last)
RS 599 499/-
(Limited period offer.Till stocks last)

More Related Content

Viewers also liked

AMP Gold Ownership Certificate
AMP Gold Ownership CertificateAMP Gold Ownership Certificate
AMP Gold Ownership CertificateHochleitner Marine
 
The evolving structure_of_gold_demand_and_supply
The evolving structure_of_gold_demand_and_supplyThe evolving structure_of_gold_demand_and_supply
The evolving structure_of_gold_demand_and_supplyHochleitner Marine
 
Portraits: a collection of portraits associated with Cottesloe, Peppermint Gr...
Portraits: a collection of portraits associated with Cottesloe, Peppermint Gr...Portraits: a collection of portraits associated with Cottesloe, Peppermint Gr...
Portraits: a collection of portraits associated with Cottesloe, Peppermint Gr...The Grove. Leading, learning, living.
 
When Sensible Sanitation is Waterless Sanitation: Real-World Ideas
When Sensible Sanitation is Waterless Sanitation: Real-World IdeasWhen Sensible Sanitation is Waterless Sanitation: Real-World Ideas
When Sensible Sanitation is Waterless Sanitation: Real-World IdeasAbigail Brown
 
Fraud cases presentation
Fraud cases presentationFraud cases presentation
Fraud cases presentationGhassan Kabbara
 
Building Facebook Apps
Building Facebook AppsBuilding Facebook Apps
Building Facebook AppsDavid Keener
 
Content area read alouds
Content area read aloudsContent area read alouds
Content area read aloudsS Bryce Kozla
 
Tõnisepäev
TõnisepäevTõnisepäev
TõnisepäevGrete
 
Tourism month calendar of events [r]
Tourism month calendar of events [r]Tourism month calendar of events [r]
Tourism month calendar of events [r]Blogatize.net
 
Eurasia21 20110301
Eurasia21 20110301Eurasia21 20110301
Eurasia21 20110301EurAsia21
 
MedicinMan December 2011
MedicinMan December 2011MedicinMan December 2011
MedicinMan December 2011Anup Soans
 
What Is Hummingbird & The Entity Search Revolution?
What Is Hummingbird & The Entity Search Revolution?What Is Hummingbird & The Entity Search Revolution?
What Is Hummingbird & The Entity Search Revolution?Mamadigital
 
Mondi virtuali, numeri e prospettive
Mondi virtuali, numeri e prospettiveMondi virtuali, numeri e prospettive
Mondi virtuali, numeri e prospettiveLuca Spoldi
 
مقرر تنظيم السنة الدراسية2012-2011
مقرر تنظيم السنة الدراسية2012-2011مقرر تنظيم السنة الدراسية2012-2011
مقرر تنظيم السنة الدراسية2012-2011Elhassan ROUIJEL
 
Pharma Field Sales Learning and Development
Pharma Field Sales Learning and DevelopmentPharma Field Sales Learning and Development
Pharma Field Sales Learning and DevelopmentAnup Soans
 

Viewers also liked (17)

AMP Gold Ownership Certificate
AMP Gold Ownership CertificateAMP Gold Ownership Certificate
AMP Gold Ownership Certificate
 
The evolving structure_of_gold_demand_and_supply
The evolving structure_of_gold_demand_and_supplyThe evolving structure_of_gold_demand_and_supply
The evolving structure_of_gold_demand_and_supply
 
Vendere con motori di ricerca e social network. Olos27102011
Vendere con motori di ricerca e social network. Olos27102011Vendere con motori di ricerca e social network. Olos27102011
Vendere con motori di ricerca e social network. Olos27102011
 
Portraits: a collection of portraits associated with Cottesloe, Peppermint Gr...
Portraits: a collection of portraits associated with Cottesloe, Peppermint Gr...Portraits: a collection of portraits associated with Cottesloe, Peppermint Gr...
Portraits: a collection of portraits associated with Cottesloe, Peppermint Gr...
 
When Sensible Sanitation is Waterless Sanitation: Real-World Ideas
When Sensible Sanitation is Waterless Sanitation: Real-World IdeasWhen Sensible Sanitation is Waterless Sanitation: Real-World Ideas
When Sensible Sanitation is Waterless Sanitation: Real-World Ideas
 
Fraud cases presentation
Fraud cases presentationFraud cases presentation
Fraud cases presentation
 
Building Facebook Apps
Building Facebook AppsBuilding Facebook Apps
Building Facebook Apps
 
Social media & law firms
Social media & law firmsSocial media & law firms
Social media & law firms
 
Content area read alouds
Content area read aloudsContent area read alouds
Content area read alouds
 
Tõnisepäev
TõnisepäevTõnisepäev
Tõnisepäev
 
Tourism month calendar of events [r]
Tourism month calendar of events [r]Tourism month calendar of events [r]
Tourism month calendar of events [r]
 
Eurasia21 20110301
Eurasia21 20110301Eurasia21 20110301
Eurasia21 20110301
 
MedicinMan December 2011
MedicinMan December 2011MedicinMan December 2011
MedicinMan December 2011
 
What Is Hummingbird & The Entity Search Revolution?
What Is Hummingbird & The Entity Search Revolution?What Is Hummingbird & The Entity Search Revolution?
What Is Hummingbird & The Entity Search Revolution?
 
Mondi virtuali, numeri e prospettive
Mondi virtuali, numeri e prospettiveMondi virtuali, numeri e prospettive
Mondi virtuali, numeri e prospettive
 
مقرر تنظيم السنة الدراسية2012-2011
مقرر تنظيم السنة الدراسية2012-2011مقرر تنظيم السنة الدراسية2012-2011
مقرر تنظيم السنة الدراسية2012-2011
 
Pharma Field Sales Learning and Development
Pharma Field Sales Learning and DevelopmentPharma Field Sales Learning and Development
Pharma Field Sales Learning and Development
 

More from Anup Soans

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...Anup Soans
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardAnup Soans
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingAnup Soans
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thAnup Soans
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMAnup Soans
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021Anup Soans
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsAnup Soans
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentAnup Soans
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramAnup Soans
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramAnup Soans
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsAnup Soans
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow Anup Soans
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectAnup Soans
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramAnup Soans
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsAnup Soans
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalAnup Soans
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollAnup Soans
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceAnup Soans
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Anup Soans
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 IssueAnup Soans
 

More from Anup Soans (20)

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way Forward
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and Spending
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAM
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand Patients
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop Talent
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification Program
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification Program
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research Project
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification Program
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian Doctors
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit Ghoshal
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View Poll
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient Experience
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 Issue
 

Indian Pharma December 2014 Highlights

  • 1. THE HEALTH OF INDIAN PHARMA MEDICINMANField Force Excellence TM January 2015 | www.medicinman.net Since 2011 Jan-Dec 2014
  • 2. BRANDST RM 2015BRAINSTORMING FOR PHARMA BRAND MANAGERS 13th March 2015, Mumbai        FFE 2015FIELD FORCE EXCELLENCE 14th March 2015, Mumbai PHARMA'S TWO MOST AWAITED EVENTS OF 2015 ARE HERE! Block the Dates: Fri, 13th & Sat, 14th March 2015 The Westin Hotel, Oberoi Garden City, Goregaon East, Mumbai Register Now!
  • 3. BRANDST RM 2015BRAINSTORMING FOR PHARMA BRAND MANAGERS MEDICINMAN Kiran Khalap Salil Kallianpur Amlesh Ranjan Manish Bhagat Susan Joshi 13th March 2015, Mumbai Anup Soans Key Topics at BrandStorm 2015 LL How to launch and sustain brands in a VUCA world LL Harnessing digital & social media LL Patient-centric care LL Medical Affairs and KOL management Target Audience: Product Managers, Group Product Managers, Marketing Managers & Digital Marketing teams First announcement; detailed program schedule to follow
  • 4. MEDICINMAN        FFE 2015FIELD FORCE EXCELLENCE 14th March 2015, Mumbai CEO Breakfast Shakti Chakraborty Bhasker Iyer Sujay Shetty Ganesh Nayak Key Topics at FFE 2015 The only pharma event in India with a CEO Roundtable on Field Force Excellence LL Managing the Millennial Field Force: Challenges & Opportunities LL Social Learning for Field Force - A viable option? LL Data Analytics: Can it provide actionable insights for segmented marketing? Target Audience: Sales & Marketing Heads, SBU Heads, Senior Managers in HR, Training, SFE and other Field Force-related functions First announcement; detailed program schedule to follow
  • 5. REGISTRATION Hosted by www.MedicinMan.net. Organized by Knowledge Media Venturz. DELEGATE FEE* MATRIX FOR FFE 2015 & BRANDSTORM 2015 All figures in INR FFE BRANDSTORM BOTH PHARMA DELEGATES 8,500/- 6,500/- 12,000/- SERVICE PROVIDERS# 15,000/- 15,000/- 25,000/- EARLY BIRD OFFER (BEFORE 20th January 2015) PHARMA DELEGATES 7,500/- 5,500/- 10,000/- SERVICE PROVIDERS# 12,500/- 12,500/- 20,000/- To register, make payment and submit payment and delegate details by email to Chhaya Sankath (chhaya@kmv.co.in) or register online: medicinman.net/2014/12/brandstorm-ffe-2015-registration CHEQUE PAYMENT Payment must be made in INR by Cheque / Bank Draft and must be received prior to the conference. Cheques to be issued in the name of “KNOWLEDGE MEDIA VENTURZ LLP”, payable at Mumbai. SEND CHEQUES TO: Chhaya Sankath, A-302, Kshitij C. H. S. L., Off Film City Road, Behind Satellite Towers, Goregaon East, Mumbai 400 063 PAY BY ACCOUNT TRANSFER NEFT DETAILS BANK: AXIS BANK BRANCH: GOREGAON WEST, MUMBAI (MH), GR FLR, PATKAR COLLEGE, S V ROAD, GOREGAON WEST, MUMBAI -62. ACCOUNT NAME: KNOWLEDGE MEDIA VENTURZ LLP ACCOUNT NO: 913020033732313 IFSC CODE: UTIB0000647 DELEGATE DETAILS (TO BE SENT ALONG WITH DETAILS OF PAYMENT) NAME: COMPANY: DESIGNATION: ADDRESS: EMAIL: MOBILE: DETAILS OF CHEQUE/ NEFT TRANSFER: PAYMENT OPTIONS *Add Service Tax @ 12.36% # Only 10 Service Provider passes available, on a first-come, first-serve basis
  • 6. Market Data: Jan-Dec 2014 Key Insights for December 2014: 1. For Month of Dec -14, we have seen the GDs as 5.1% in Volumes, 5.3% in Price Increases & 3.2% in NIs against a 4.1% in volumes in Dec -13 2. Price Increases was at 5.3%, which has been the highest in the last 12 months in the IPM 3. There has been a growth registered (10.3%) in this quarter which is higher than the corresponding Quarter last year (4.3%) Key Highlights for December 2014: Key Numbers: 1. The IPM clocked 7375 Crs in December 2014 2. The Indian Pharma Market grows at 13.6% for the month of December 2014 Corporate: 1. For the month of December 2014, amongst the top 10, Ranbaxy grew by 28.7% followed by Pfizer at 23.1% & Sun Pharma at 21.5% 2. 21 corporate have crossed the growth of IPM for the month of December 2014 amongst top 50 3. Amongst the top 50 Corporate, Akumentis has the highest growth of 69.4% followed by Merck at 37.8% & Albert David at 32.0% 4. 30 Corporate showed growths more than 10% amongst the top 50 5. Amongst the 11-20 ranked Corporate Torrent has the highest growth of 31.1% followed by Macleods at 30.1% & USV at 24.9% After the peak in Sep 2014, the market showed a dip due to festive season, however for last 2 months the market has be in a positive trend with Dec month at 13.6% Source: AIOCD Pharmasofttech AWACS The Health of Indian Pharma: Jan-Dec 2014MEDICINMAN
  • 7. 6. Amongst the 51-60 ranked Corporate, Panacea grows at 42.0% followed by Pharmed at 17.7% & Systopic at 17.2% 7. Amongst the 61-75 ranked Corporate, Boehringer grew by 62.1% followed by Tablets India at 23.3% & Serdia at 18.8% 8. Ranbaxy enters the 3000 Cr Club, Panacea enters the 300 Cr Club as on MAT Dec 2014 Indian V/S MNCs: 1. Indian companies have grown at 12.1% versus 17.5% for MNCs in December 2014 2. Amongst the top 50 in MNCs Merck grew by 37.8% followed by Ranbaxy at 28.7%, MSD at 26.1% & Pfizer at 24.3% 3. Under the Non-NLEM category Indian Companies grew at 13.6% whereas MNCs grew at 18.0% 4. For the Dec Quarter the MNCs have shown a volume growth of 6.4% versus 1.0% for the Indian companies 5. DPCO V/s Non DPCO Market: 6. The DPCO containing molecules market grew at 8.0 % whereas the non DPCO market grew by 14.8% resulting in an overall growth of 13.6% for December 2014 7. NLEM & Non - NLEM Category showed unit growth at 0.7% and 3.2% respectively 8. The DPCO 2013 portfolio for Pfizer grew at 13.9%, GSK 1.7%, Ranbaxy 41.9% December 2014 Val in Cr Units in 000s Value Growth Unit Growth IPM 7,357 13.6% 1,579,638 2.7% NLEM 1,252 8.0% 320,126 0.7% Non-NLEM 6,123 14.8% 1,259,512 3.2% Source: AIOCD Pharmasofttech AWACS The Health of Indian Pharma: Jan-Dec 2014MEDICINMAN
  • 8. Therapy: 1. From therapy perspective 4 therapies have outgrown the IPM growth & 14 therapies have double digit growths 2. Respiratory Market grew at 10.0%, Gastrointestinal market grew at 13.5% , Pain & Analgesics market grew at 11.3% whereas Anti-infectives grew at 5.2% 3. Anti-diabetic market grows at 33.1% & Cardiac at 18.2% in chronic business 4. Derma market grew by 19.6% & Urology Market at 29.7% Regional Dynamics: 1. From regional perspective 11 regions have outgrown the IPM growth 2. Mumbai market grew the highest at 21.9% followed by Gujarat market at 21.7% & Kerala Market at 20.7% 3. No regions had negative growth in December 2014 Molecules: 1. Amoxycillin + Clavulanic Acid Market grew at 8.2% whereas Glimepiride + Metformin grows at 20.0% at No 2. 2. The markets of Paracetamol grew at 5.6%, Atorvastatin 24.0%, Probiotic Microbes at 26.9%, Cefixime 1.1%, Pantoprazole 15.3%, Montelukast + Levocetrizine at 20.4%, Glimepiride + Metformin + Pioglitazone at 28.1%, Vitamin-D at 29.4%, Hydroquinone + Mometasone + Tretinoin at 34.7%, Voglibose + Metformin + Glimepiride at 57.0%, Leveteracetam at 37.2%, Protein Supplements at 24.1% Brands: 1. Mixtard continues to lead the pack with 41.7 Crs for the Month of Dec -14 with a growth of 47.8% 2. Mixtard grew at 47.8%, Lantus grew at 36.7% & Glycomet- GP grows at 36.3%, Augmentin grows at 16.2%, amongst the top 10 Brands 3. Amongst the Brands who have gained ranks include Clexane (+64), Janumet (+54), Januvia (+43), Shelcal (+38), Panderm Plus (+31), Istamet (+29), Rosuvas & Jalra (+26), Novomix, Susten & Jalra-M (+17), Taxim, Pan & Levipil (+15), Zincovit (+13), Dexorange, Orofer-XT & Tonact (+9), Liv -52(+6), amongst Top 100 Brands over December 13 New Launches in IPM: 1. Total 361 SKUs & 185 Brands launched in December 2014 2. Top New Brands for December are Biovac V, Ryzodeg & Canmab 3. 2 New Subgroups got launched as Roflumilast & Cyclobenzaparine + Diclofenac Source: AIOCD Pharmasofttech AWACS The Health of Indian Pharma: Jan-Dec 2014MEDICINMAN
  • 9. CAREERPROGRESSIONRESOURCES NOWAVAILABLEON (click on the books to purchase on flipkart) SuperVision for the SuperWiser Front-line Manager is a tool to help pharma professionals transition from super salesmen to great front-line managers and leaders. The book will equip front-line managers to Manage, Coach, Motivate and Lead their teams to deliver outstanding performance. An engaging read, filled with examples and illustrations, SuperVision for the SuperWiser Front-line Manager has been used by thousands of managers across the industry. HardKnocks for the GreenHorn is a specially crafted training manual to enable Medical Representatives to gain the Knowledge, Skills and Attitude needed to succeed in the competitive arena of pharma field sales. Medical Representatives joining the field are often not aware about the key success factors of their job and as a result they get discouraged when things don’t go as planned. HardKnocks for the GreenHorn is a powerful learning and motivational tool for field sales managers to build their sales teams. RS 799 699/- (Limited period offer.Till stocks last) RS 599 499/- (Limited period offer.Till stocks last)